avatar_Oval 5

Hormontherapie in der Menopause erhöht das Bluthochdruckrisiko

Begonnen von Oval 5, 17.07.2012, 06h04

vorheriges - nächstes

Oval 5

Zitat von: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040260Menopausal Hormone Therapy Is Associated with Having High Blood Pressure in Postmenopausal Women: Observational Cohort Study
Christine L. Chiu1, Sanja Lujic1, Charlene Thornton1, Aiden O'Loughlin1, Angela Makris1,2, Annemarie Hennessy1, Joanne M. Lind1*

1 School of Medicine, University of Western Sydney, Penrith, New South Wales, Australia, 2 Department of Renal Medicine, Liverpool Hospital, Liverpool, Sydney, Australia

............
Conclusions
Menopausal hormone therapy use is associated with significantly higher odds of having high blood pressure, and the odds increase with increased duration of use. High blood pressure should be conveyed as a health risk for people considering MHT use.

..........
Ergebnis:
Hormontherapie zur Behandlung von Problemen in der Menopause ist mit einer signifikat erhöhten Wahrscheinlichkeit von zu hohem Blutdruck verbunden und die Wahrscheinlichkeit steigt mit erhöhter Hormondosierung. Frauen, die eine MHT in Erwägung ziehen sollten über Bluthochdruck als gesundheitsgefährdende Nebenwirkung aufgeklärt werden   


Zitat von: http://www.plosone.org/article/info:doi/10.1371/journal.pone.0040260Citation: Chiu CL, Lujic S, Thornton C, O'Loughlin A, Makris A, et al. (2012) Menopausal Hormone Therapy Is Associated with Having High Blood Pressure in Postmenopausal Women: Observational Cohort Study. PLoS ONE 7(7): e40260. doi:10.1371/journal.pone.0040260

Editor: Pedro A. Jose, University of Maryland School of Medicine, United States of America


Received: March 27, 2012; Accepted: June 4, 2012; Published: July 11, 2012

Copyright: © 2012 Chiu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Funding: Dr. Lind is supported by a National Health and Medical Research Council (NHMRC) Fellowship (Australia). www.nhmrc.gov.au. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.

* E-mail: j.lind@uws.edu.au